Quantcast

MEDRAD Adds Multi Vendor Service to ISO 13485:2003 Certification

June 24, 2008

MEDRAD, INC., announced today that its Multi Vendor Service was added to MEDRAD’s ISO 13485:2003 certification, making it one of only two major providers of ultrasound transducer and MRI coil repair services with the certification.

Multi Vendor Service achieved this new certification by demonstrating to the International Organization for Standards (ISO) that it has quality systems in place to ensure high-quality product and repair service.

“This certification, paired with over 40 years of commitment to quality at MEDRAD, affirms our Multi Vendor Service organization’s first-rate repair process to our customers,” said Diane Watson, executive director of Multi Vendor Service. “We are able to accomplish this while providing significant cost savings over OEM offerings.”

ISO 13485:2003, which is closely related to the ISO 9000 standards for quality management systems, is the international standard for the medical device industry. It specifies requirements for quality systems that demonstrate a company’s ability to provide medical devices and related services that consistently meet customer needs and regulatory requirements.

MEDRAD’s Multi Vendor Service team provides OEM-quality repairs for all brands of MRI coils, ultrasound transducers and ultrasound parts in locations around the world. Multi Vendor Service repairs nearly 400 different makes and models of MRI coils and 300 types of ultrasound probes, in addition to providing comprehensive replacement and sourcing capabilities.

About MEDRAD, INC.

MEDRAD, INC., is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD’s product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2007 revenues were $525 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company’s world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG. More company information is available at www.medrad.com.

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD’s plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD, INC. undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.

 For additional information contact: Bill Kollitz MEDRAD Multi Vendor Service 412-767-2400 ext. 5060 Email Contact  Dan Dieter MEDRAD Marketing Services 724-940-6949 Email Contact

SOURCE: MEDRAD, INC.




comments powered by Disqus